Tested Applications
| Positive WB detected in | COLO 320 cells, Jurkat cells, BxPC-3 cells, A375 cells |
| Positive IP detected in | COLO 320 cells |
| Positive IHC detected in | human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12125-1-AP targets RAB22A in WB, IHC, IF, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, canine, hamster |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2769 Product name: Recombinant human RAB22A protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-194 aa of BC015710 Sequence: MALRELKVCLLGDTGVGKSSIVWRFVEDSFDPNINPTIGASFMTKTVQYQNELHKFLIWDTAGQERFRALAPMYYRGSAAAIIVYDITKEETFSTLKNWVKELRQHGPPNIVVAIAGNKCDLIDVREVMERDAKDYADSIHAIFVETSAKNAININELFIEISRRIPSTDANLPSGGKGFKLRRQPSEPKRSCC Predict reactive species |
| Full Name | RAB22A, member RAS oncogene family |
| Calculated Molecular Weight | 194 aa, 22 kDa |
| Observed Molecular Weight | 22 kDa |
| GenBank Accession Number | BC015710 |
| Gene Symbol | RAB22A |
| Gene ID (NCBI) | 57403 |
| RRID | AB_2173765 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UL26 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
RAB22A is a small GTPase that is expressed ubiquitously in mammalian tissues. It localizes in the MHCI-containing recycling endosomal tubules and functions in endocytic pathway. RAB22A may regulate the dynamic interactions of endosomal compartments and it may be involved in the communication between the biosynthetic and early endocytic pathways. It shares 81% identity with RAB31.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for RAB22A antibody 12125-1-AP | Download protocol |
| IP protocol for RAB22A antibody 12125-1-AP | Download protocol |
| WB protocol for RAB22A antibody 12125-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RAB22A Polyclonal antibody (Cat# 12125-1-AP) has 28 citations spanning journals including Nature Cell Biology, Advanced Science, Oncogene, EMBO Reports, Journal of Extracellular Vesicles, Clinical Cancer Research, and Molecular Biology of the Cell. Research fields cover endosomal trafficking and recycling, exosome/microvesicle biology, cancer (colorectal, breast, gastric, hepatocellular, melanoma), chemoresistance, neurobiology, prion disease, and macrophage-mediated invasion. Applications include WB, IF, IHC, and IP across human, mouse, and other species.
| Species | Application | Title |
|---|---|---|
J Extracell Vesicles RAB22A sorts epithelial growth factor receptor (EGFR) from early endosomes to recycling endosomes for microvesicles release
| ||
Adv Sci (Weinh) RNA-Binding Protein RBM25 Targets the mRNA Stability of GTPase Rab22a to Restrict Viral Entry and Infection. | ||
Adv Sci (Weinh) Genomic Amplification of TBC1D31 Promotes Hepatocellular Carcinoma Through Reducing the Rab22A-Mediated Endolysosomal Trafficking and Degradation of EGFR
| ||
J Control Release An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy | ||
Int J Biol Sci Hypoxia preconditioned renal tubular epithelial cell-derived extracellular vesicles alleviate renal ischaemia-reperfusion injury mediated by the HIF-1α/Rab22 pathway and potentially affected by microRNAs. |











